The University of Chicago Header Logo

Connection

Wendy Stock to Vascular Endothelial Growth Factor A

Back to Details
This is a "connection" page, showing publications Wendy Stock has written about Vascular Endothelial Growth Factor A.
Wendy Stock
Connection Strength
0.067
Vascular Endothelial Growth Factor A
  1. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2008 May 01; 14(9):2756-62.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.